Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by longterm56on Jan 21, 2022 9:05am
122 Views
Post# 34341520

RE:RE:RE:RE:RE:RE:RE:Meetings with Large Holders

RE:RE:RE:RE:RE:RE:RE:Meetings with Large HoldersYou missed my point ... my point was not about all the things they are doing ... it was about the minimal amount that they have made public and would be able to discuss next week at a private meeting.

   -LT


palinc2000 wrote:

We got confirmation yesterday that they had crossed an important theshold in dosage  and they were on ro the next level.... Tou seem to forget that safety or lack of toxicity is not a foregone conclusion ... they are dealing with humans not mice....Fast track designation does not mean that they dont follow safety protocols...Patients are enrolling in the hope of getting cured not roasted!!!!
Relax!!!!

longterm56 wrote: I hope the large shareholders express their frustration for being called to a meeting where they are told  ...

   "Things are going well, but we haven't reached the MTD yet ... thanks for coming."

   -LT


 

 

SPCEO1 wrote: You are right about those being strong hints of something important happening. And there are others as well. But unless they come out with a PR on something inthe next few days, we will all still be scratching our heads.

mikeq113 wrote:

If there is nothing new to report why take down the corporate presentation for the last month? Why initiate meeting with groups of shareholders that represent sizable positions in your company just to bore them and (intentionally or unintentionally) waste their time with the same information you provided months ago? 

It just doesn't add up to me, but unfortunately I am often left scratching my head when it comes to many of the decisions made by this company. 


 

 




<< Previous
Bullboard Posts
Next >>